TrialMedical oncology (Northwood, London, England)2019

Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study.

Masaki Shiota et al.PubMed ↗Publisher ↗

No numbers read from the abstract.